首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1623381

全球穿戴式註射器市場規模（按類型、療法、最終用戶、地區、範圍和預測）

Global Wearable Injector Devices Market Size By Type (On-Body Injectors, Off-Body Injectors), By Therapy (Immuno-Oncology, Diabetes), By End-User (Hospitals, Clinics), By Geographic Scope And Forecast

出版日期: 2024年08月17日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

穿戴式註射器市場規模及預測

2023 年穿戴式註射器市場規模價值 86.2 億美元，預計到 2031 年將達到 187.7 億美元，2024 年至 2031 年的複合年增長率為 10.21%。可穿戴注射器用於使用傳統手持便攜式設備來注射藥物。它是一種自我擴展、自我管理的系統，患者可以使用它定期服藥。對於患有糖尿病、肥胖症和高血壓等慢性疾病的人來說，它是必不可少的。穿戴式註射器可以在仔細監控的情況下提高醫療液體的精確輸送。它廣泛應用於醫院、家庭護理機構、診所等。糖尿病、心血管疾病和癌症等慢性病的發生率不斷上升，以及單株抗體等生物製劑在治療疾病方面的應用日益廣泛，以及智慧型手機藍牙連接的使用日益增多，由於研發力度不斷加大，市場正在不斷擴大具有指紋識別和數位顯示等功能的可穿戴注射器的活動。

老年患者數量的增加和家庭護理的需求正在推動市場向前發展。此外，醫療保健基礎設施的完善和生活方式疾病的發生率不斷增加是推動市場擴張的另外兩個因素。然而，穿戴式註射器市場預計將受到新興市場需求低和穿戴式註射器高成本的限制。

穿戴式註射器有望解決醫療保健基礎設施和互聯醫療服務的主要差距。由於患有慢性肺部、心血管和神經系統疾病的患者開始控制其長期影響，由於 COVID-19 導致的慢性病增加可能成為穿戴式註射器應用發展的驅動力。患有慢性病的患者要求從診所服藥改為在家服藥，以避免接觸新冠病毒。

穿戴式註射器的全球市場動態

影響全球穿戴式註射器市場的關鍵市場動態

主要市場驅動因子

慢性病發生率不斷上升

糖尿病、癌症和自體免疫疾病等慢性疾病的發生率不斷上升，需要頻繁且精確的藥物輸送，因此需要一種可穿戴注射器裝置來提供簡單有效的治療選擇。

技術進步

穿戴式技術的技術進步，例如改進的材料、小型化和無線通信，正在提高可穿戴注射器的功能性和易用性，使其對患者和醫療保健專業人員更具吸引力。

病人對居家照護的偏好：

為了減少就診次數和醫療費用，自我用藥和居家照護正成為日益增長的趨勢。穿戴式註射器為患者獨立管理治療提供了有效的解決方案。

支持性監理政策：

有利的監管框架和 FDA、EMA 等衛生當局對穿戴式註射器的日益增加的批准將推動市場成長。這些政策確保了穿戴式註射器的安全性、有效性和質量，鼓勵其在臨床實踐中的應用。

主要問題

監管障礙與合規性：

應對複雜且具課題性的監管環境是穿戴式註射器面臨的主要障礙。製造商必須確保其產品符合包括 FDA 和 EMA 在內的多個全球衛生機構的監管標準。這需要大量的測試和文件來證明安全性和有效性，這既費時又昂貴。不合規可能會導致產品審批和市場進入延遲，從而影響收入和市場競爭。

技術與設計課題：

製造一種易於使用、可靠且能夠精確輸送多種藥物的可穿戴注射器存在重大技術障礙。將連接性和自動藥物傳輸等先進功能結合起來，同時保持設備小巧、輕便和舒適，需要專門的工程設計。在各種天氣條件和使用情況下維持設備性能使問題更加複雜。

市場接受度與採用率：

獲得醫療專業人士和患者的接受和採納至關重要，但也很困難。對新技術的不熟悉以及對安全性和有效性的擔憂常常會導致抵制。克服這些障礙需要教育利益相關者，展現其好處，並確保設備可以輕鬆整合到現有的醫療保健實踐中。患者的依從性也很重要，因此設計必須直觀且不引人注目。

費用和報銷問題：

穿戴式註射器的開發和製造成本很高，並且在定價和市場滲透方面存在課題。獲得保險公司的報銷對於更廣泛的應用來說很重要，但如果沒有成本效益和臨床優勢的有力證據，則會很困難。製造商必須與付款人合作制定有利的報銷途徑，其中可能包括昂貴的臨床研究和健康經濟研究。

主要趨勢：

技術進步與創新：

由於穿戴式註射器配備智慧功能等技術進步，市場正在迅速擴大。這些功能包括藍牙連接、即時監控和應用程式集成，以提高患者的依從性並為醫療保健提供者提供有用的數據。

慢性病發生率不斷上升：

糖尿病、癌症和自體免疫疾病等慢性疾病的發生率不斷上升，推動了對穿戴式註射器的需求。這些設備為管理長期處方方案提供了一種實用有效的方法，並透過實現家庭護理提高了患者的生活品質。

以病人為中心的醫療保健解決方案：

對以患者為中心的醫療保健的日益重視推動了可穿戴注射器的引入。這些設備的設計易於使用、可減少不適並可進行自我注射。此舉使人們能夠自主掌控自己的醫療護理，進一步推動了個人化醫療的趨勢。

監理機關核准與市場擴張：

隨著穿戴式註射器在世界各地獲得監管部門的批准，市場正在開放。這不僅擴大了可用性，而且增強了客戶對其安全性和有效性的信心。此外，公司正在透過策略聯盟和合作來擴大其市場佔有率，從而擴大其產品的影響力和採用率。

Wearable Injector Devices Market size was valued at USD 8.62 Billion in 2023 and is projected to reach USD 18.77 Billion by 2031 , growing at a CAGR of 10.21% from 2024 to 2031. Wearable injectors are used to give drugs through a conventional handheld portable device. It is a self-scalable, self-administration system that patients use to take their medication on a regular basis. It is essential for people suffering from chronic conditions like diabetes, obesity, and hypertension. The wearable injector improves the accurate delivery of medical fluid under careful supervision. It is widely used in hospitals, home care facilities, clinics, and other settings. The market is growing due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer, as well as the increased use of biologics such as monoclonal antibodies for disease treatment and increased R&D activities in wearable injector devices with features such as Bluetooth connectivity with a smartphone and a digital display.

The growing number of geriatric patients and demand for home-based therapy are moving the market ahead. Furthermore, the presence of well-established healthcare infrastructure, as well as an increase in the frequency of lifestyle-related disorders, are two other factors driving market expansion. However, the Wearable Injector Devices Market is projected to be restrained by low demand in developing nations and the high costs associated with wearable injectors.

Wearable injectors are expected to solve significant gaps in healthcare infrastructure and connected health services. As patients with chronic pulmonary, cardiovascular, and neurological problems begin to manage the long-term consequences of the condition, an increase in chronic ailments caused by COVID-19 morbidity may help drive development in the adoption of wearable injectors. Patients with chronic conditions are asking a switch from clinic to at-home drug administration to avoid COVID-19 exposure.

Global Wearable Injector Devices Market Dynamics

The key market dynamics that are shaping the global Wearable Injector Devices Market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases

: The rising prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders needs frequent and precise drug delivery, resulting in a desire for wearable injector devices that provide simple and effective treatment choices.

Technological Advancements

: Technological advancements in wearable technology, including as improved materials, downsizing, and wireless communication, improve the functionality and usability of wearable injectors, making them more appealing to patients and healthcare professionals.

Patient Preference for Home-Based Care:

There is a growing trend towards self-administration of medications and home-based care, fueled by the desire to reduce hospital visits and healthcare costs. Wearable injectors provide an efficient solution for patients to manage their treatment independently.

Supportive Regulatory Policies:

Favorable regulatory frameworks and increased approvals of wearable injector devices by health authorities like the FDA and EMA facilitate market growth. These policies ensure the safety, efficacy, and quality of wearable injectors, boosting their adoption in clinical practice.

Key Challenges:

Regulatory Hurdles and Compliance:

Navigating the complicated and strict regulatory landscape is a significant hurdle for wearable injector devices. Manufacturers must guarantee that their products meet the regulatory standards of several worldwide health bodies, including the FDA and EMA. This entails extensive testing and documentation to prove safety and efficacy, which can be time-consuming and expensive. Non-compliance can cause delays in product approval and market access, affecting revenue and competitiveness.

Technological and Design Challenges:

Creating wearable injector devices that are user-friendly, dependable, and capable of precisely delivering a wide range of drugs has substantial technical obstacles. Keeping the gadgets small, lightweight, and comfy while combining advanced capabilities like connection and automated drug delivery necessitates expert engineering. Maintaining device performance under a variety of weather settings and usage scenarios further complicates matters.

Market Acceptance and Adoption:

Gaining acceptance and adoption from healthcare professionals and patients is crucial but difficult. Unfamiliarity with new technologies, as well as concerns about safety and efficacy, frequently cause resistance. Overcoming these barriers requires educating stakeholders, demonstrating advantages, and ensuring that the devices integrate easily into existing healthcare practices. Patient adherence is also critical, thus designs must be intuitive and least obtrusive.

Cost and Reimbursement Issues:

Wearable injector devices can be costly to develop and manufacture, offering pricing and market penetration challenges. Receiving reimbursement from insurance companies is critical for wider adoption, but this can be difficult without strong evidence of cost-effectiveness and clinical advantages. Manufacturers must collaborate with payers to build advantageous reimbursement routes, which can include costly clinical studies and health economic studies.

Key Trends:

Technological Advances and Innovations:

The market is expanding rapidly as a result of technological advances such as the incorporation of smart features into wearable injectors. These features include Bluetooth connectivity, real-time monitoring, and app integration, which improve patient compliance and give useful data to healthcare providers.

Increasing Prevalence of Chronic Diseases:

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune disorders is fueling demand for wearable injectors. These devices provide a practical and effective approach to managing long-term prescription regimens, enhancing patient quality of life by allowing for at-home care.

Patient-Centered Healthcare Solutions:

The rising emphasis on patient-centered healthcare is driving the introduction of wearable injectors. These devices are designed to be user-friendly, reducing discomfort and allowing for self-administration. This move advances the trend of individualized medicine by empowering people to manage their own care.

Regulatory Approvals and Market Expansion:

The market is developing as more wearable injectors obtain regulatory authorization around the world. This not only expands their availability but also raises customer trust in their safety and efficacy. Furthermore, organizations are increasing their market presence through strategic alliances and collaborations, which improve product reach and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Wearable Injector Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Wearable Injector Devices Market:

North America:

North America has a well-developed healthcare infrastructure that facilitates the introduction of innovative medical technologies, such as wearable injector devices. The existence of world-class hospitals, research institutions, and healthcare facilities enables the rapid integration of these devices into patient care. Furthermore, the region has strong healthcare funding and reimbursement rules that promote innovation and use of cutting-edge medical technologies.

The increased prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease in North America fuels demand for wearable injector devices. These devices provide a simple and effective way to manage long-term pharmaceutical regimens, which is critical for patients with chronic diseases. The growing number of patients requiring ongoing therapy creates a significant market for these advanced drug delivery systems.

North America's strong regulatory environment protects the safety and efficacy of medical products, boosting consumer confidence. Regulatory bodies such as the FDA establish clear guidelines and pathways for the approval and commercialization of wearable injectors. This regulatory support not only speeds up the introduction of innovative technologies to the market, but it also reassures healthcare providers and patients about their dependability.

The region is a hotbed of technical innovation and healthcare-related research and development. Companies and research organizations in North America are investing extensively in next-generation wearable injectors with advanced features including connectivity and real-time monitoring. This ongoing focus on innovation improves product offerings and establishes North America as a market leader in wearable injector devices.

Asia Pacific:

Asia Pacific is experiencing significant expansion in healthcare infrastructure, which is fueling the growth of the Wearable Injector Devices Market. Governments throughout the area are raising healthcare budgets and investing in cutting-edge medical technologies to improve patient care. This investment promotes the use of novel equipment such as wearable injectors in hospitals and clinics. Improved healthcare facilities attract a larger patient population, which fuels market expansion.

Diabetes, cancer, and cardiovascular disease are all on the rise in the region. This surge in chronic illnesses needs long-term and efficient treatment alternatives, making wearable injectors an intriguing solution. These technologies enable patients to manage their diseases at home, minimizing the need for frequent hospital visits. The expanding patient population, with chronic diseases boosts the demand for wearable injectors.

Economic expansion in countries such as China, India, and Japan is resulting in increasing disposable incomes and healthcare spending among the population. People with larger financial means are more inclined to invest in innovative healthcare solutions, such as wearable injector devices. Furthermore, increased healthcare knowledge and education are encouraging people to seek out better and more convenient treatment options, hence promoting market growth.

The regulatory climate in Asia Pacific is becoming more conducive to medical device innovation and commercialization. Governments are creating favorable regulations and expediting the approval process for new medical technologies. This creates a favorable environment for the introduction and use of wearable injector devices. The ease with which regulatory licenses are granted increases market entry and expansion for regional producers and distributors of such devices.

Global Wearable Injector Devices Market: Segmentation Analysis

The Global Wearable Injector Devices Market is Segmented on the basis of Type, Therapy, End-User, And Geography.

Wearable Injector Devices Market, By Type

On-Body Injectors
Off-Body Injectors

Based on Type, the market is segmented into On-Body Injectors and Off-Body Injectors. On-body wearable injectors accounted for the greatest revenue share in 2023, owing to rising demand because these patches are pleasant to wear on the skin (stomach), are water resistant, and are convenient to use at home. On-body wearable injectors have several advantages, including fewer hospital visits, lower healthcare costs, lifecycle management, customizable dosing, and automatic warming of cold medications. Off-body wear removes hazards such as painful device removal, adhesive fitting difficulties, and skin sensitivity or irritation.

Wearable Injector Devices Market, By Therapy

Immuno-Oncology
Diabetes
Cardiovascular Diseases

Based on Therapy, The market is segmented into Immuno-Oncology, Diabetes, and Cardiovascular Diseases. During the projection period, the diabetes category has the most share. This category's significant position may be attributable to the rising prevalence of diabetes worldwide, as well as the increasing availability of wearable injectors for the treatment of chronic diseases, which is moving this market segment forward.

Wearable Injector Devices Market, By End-User

Hospitals
Home Care Settings
Clinics

Based on End-User, The market is segmented into Hospitals, Home Care Settings, and Clinics. The hospital and clinic segment has a larger market share. The growing preference for self-administration of medication, as well as the growing need to cut healthcare costs, can be attributed to this segment's significant share. Furthermore, the growing need for technologically advanced drug administration systems that lower hospitalization rates while requiring minimal expertise is expected to drive the home healthcare settings market ahead.

Wearable Injector Devices Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, The Global Wearable Injector Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Wearable Injector Devices Market in North America is the world's largest. The high prevalence of chronic and lifestyle-related illnesses, as well as the availability of advanced healthcare infrastructure in the region, account for North America's large share of this market.

Key Players

The "Global Wearable Injector Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Valeritas, SteadyMed Therapeutics, Tandem Diabetes Care, Amgen, Medtronic, Insulet Corporation, United Therapeutic Corporation, Enable Injections, Ypsomed and Becton, Dickinson and Company.
The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Wearable Injector Devices Market Recent Developments
In February 2023, Insulet Corporation purchased the assets of Automated Glucose Control LLC (AGC), a firm dedicated to developing and marketing best-in-class automated insulin delivery technology. The company participated in the creation of Omnipod (Insulet's flagship product).
In January 2023, Tandem purchased Capillary Biomedical, an infusion set developer.
In July 2022, Becton Dickinson and Company purchased Parata Systems. This acquisition will assist BD's market growth.
In January 2022, enable injections were obtained. The company obtained USD 215 million in Series C investment. The cash will be used to onboard Enable Injections and major new pharma partner initiatives, as well as to speed the commercialization of their products and platforms with existing pharma partners.
In September 2021, Ypsomed AG introduced the YpsoDose single-use injector, which is an electromechanical pre-filled and pre-assembled patch device for 10 mL glass cartridges. Automatically completed steps include needle insertion, injection, end-of-injection feedback, and needle safety. The needle is kept hidden at all times and is rendered safe following injection and device removal.